King Saud University
ksu.edu.saTotal trials
162
Active
18
Phase 3
12
Total enrollment
33,622
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Metformin | — | — | — | — | — | 1 |
Next readouts
- 2025-08-01
Top conditions
- Stroke8
- Knee Osteoarthritis5
- Chronic Periodontitis4
- Muscle Strength4
- Obesity4
- Cerebral Palsy2
- Hemiparesis of the Upper Limb Following Stroke2
- Head and Neck Cancer2
Frequently asked questions about King Saud University
- How many clinical trials does King Saud University have on ClinicalTrials.gov?
- King Saud University is listed as the lead sponsor on 162 clinical trials in ClinicalTrials.gov, 18 of which are currently active (recruiting, enrolling, or ongoing).
- How many of King Saud University's trials are in Phase 3?
- 12 of King Saud University's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does King Saud University focus on?
- King Saud University's most-studied conditions on ClinicalTrials.gov are Stroke, Knee Osteoarthritis, Chronic Periodontitis, Muscle Strength, Obesity.
- When are King Saud University's next clinical trial readouts?
- King Saud University has 1 upcoming primary-completion readout tracked here; the soonest is “Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes”, expected around 2025-08-01.